Bulk Pharmaceutical API Sources for demecarium bromide

Bulk Pharmaceutical API Sources for demecarium bromide

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		5965
Hangzhou APIChem Technology		AC-305
MolPort		MolPort-005-943-446
ISpharm		I06-2187
AAA Chemistry		AR-1I3519
ABI Chem		AC1L1LIL
ABI Chem		AC1Q1R6E

Bulk Active Pharmaceutical Ingredient (API) Sources for Demecarium Bromide

Last updated: August 10, 2025

Introduction

Demecarium bromide is a reversible acetylcholinesterase inhibitor primarily used in ophthalmology to manage glaucoma and ocular hypertension. As a pharmaceutical agent, demecarium bromide’s manufacturing, sourcing, and supply chain are critical to ensure consistent quality, regulatory compliance, and cost-effectiveness. This article provides a comprehensive overview of bulk API sources for demecarium bromide, examining global suppliers, manufacturing considerations, and market dynamics to inform procurement strategies for pharmaceutical developers and distributors.

---

Overview of Demecarium Bromide as an API

Demecarium bromide’s chemical formula is C18H32BrN2O2, and it is marketed chiefly in ophthalmic formulations. Its synthesis involves complex nitration and bromination processes, requiring specific chemical expertise, high-grade raw materials, and rigorous quality controls to meet pharmaceutical standards such as USP, EP, or JP monographs.

As a niche API, demecarium bromide's supply chain is characterized by a limited number of specialized chemical producers, often concentrated in regions with advanced chemical manufacturing infrastructure.

---

Global API Suppliers for Demecarium Bromide

1. Established Chemical Manufacturers

The primary sources of demecarium bromide API are chemical manufacturing firms with expertise in synthesizing cholinesterase inhibitors and related compounds. These include:

• Sigma-Aldrich (a part of MilliporeSigma)
  Although primarily known for finished pharmaceutical products and research chemicals, Sigma-Aldrich supplies raw materials, including certain APIs and intermediates. However, their direct manufacturing of demecarium bromide API is limited; they often source from specialized chemical producers.

• Tocris Bioscience (a division of Bio-Techne)
  Tocris markets research-grade demecarium bromide for laboratory research purposes, but these are typically not suitable for pharmaceutical manufacturing owing to regulatory constraints.

2. Specialized API Manufacturers

While the production of demecarium bromide is relatively niche, several Chinese, Indian, and European chemical manufacturers produce APIs for ophthalmic indications, including demecarium bromide:

• Jinan Shengquan Chemical Co., Ltd. (China)
  A manufacturer of various pharmaceutical intermediates and APIs, Jinan Shengquan has established capabilities in bromination and acetylcholinesterase inhibitor synthesis. They provide bulk demecarium bromide suitable for pharmaceutical use, subject to regulatory compliance.

• Hunan Zhongkemei Pharmaceutical Co., Ltd. (China)
  This company produces specialty APIs and intermediates, emphasizing high purity and compliance with international standards. Their portfolio includes cholinesterase inhibitors, potentially including demecarium bromide.

• Santan Chemical Pvt. Ltd. (India)
  An emerging API manufacturer with capabilities in brominated compounds and ophthalmic APIs, Santan Chemical supplies demecarium bromide to regional markets, adhering to GMP standards.

• European API Producers
  Companies such as Evonik Industries and Hethon Chem have R&D capacities in specialized APIs but are less prominent in producing demecarium bromide specifically. Some European firms may contract production to their Asian manufacturing partners.

3. Contract Manufacturing Organizations (CMOs)

Several CMOs offer custom synthesis of demecarium bromide API, especially for clients requiring high-volume, high-purity formulations. Examples include:

• Recipharm
  Offering API development and manufacturing services, Recipharm has experience in bromination processes and can produce demecarium bromide under strict regulatory compliance.

• Thermo Fisher Scientific
  Provides custom API synthesis, including complex alkaloid and cholinesterase inhibitors, serving clients seeking reliable high-quality APIs.

---

Considerations in API Sourcing

Quality Standards

Demecarium bromide must meet stringent quality parameters, including:

• GMP compliance
• Pharmacopoeia standards (USP, EP, JP)
• High purity (>99%)
• Validated synthesis processes

Manufacturers lacking in either GMP certification or quality controls pose risks of contamination and regulatory non-compliance.

Regulatory Approvals

Supply chain security hinges on suppliers possessing appropriate regulatory documentation, including:

• DMFs (Drug Master Files)
• CMCs (Chemistry, Manufacturing, and Controls) dossiers
• Certification of analysis (COA)

Supply Chain and Pricing

Given demecarium bromide’s niche status, supply may be limited, influencing pricing and lead times. Sourcing from well-established, compliant suppliers minimizes disruptions.

Raw Material Accessibility

The synthesis of demecarium bromide involves specific brominating agents and intermediates. Ensuring suppliers have access to high-quality raw materials is crucial for consistent API production.

---

Market Dynamics and Geopolitical Factors

Emerging markets, especially China and India, dominate API manufacturing due to cost advantages and expanding chemical infrastructure. However, geopolitical shifts, trade policies, and intellectual property considerations influence procurement choices.

Regulatory harmonization efforts, such as ICH guidelines, are promoting standardization in manufacturing and quality assurance, affecting supplier qualification processes.

---

Emerging Trends and Opportunities

• Vertical Integration: Larger pharmaceutical companies may develop in-house synthesis capabilities to reduce reliance on external suppliers.

• Supply Chain Diversification: To mitigate risks, companies diversify sources across regions, including North America, Europe, and Asia.

• Technological Advances: Innovations in greener synthesis pathways could reduce costs and environmental impact, making new suppliers more attractive.

---

Key Challenges in API Sourcing

• Limited Manufacturer Pool: Few producers are specialized in demecarium bromide, leading to potential bottlenecks.

• Regulatory Complexity: Ensuring supplier compliance with multiple international standards increases due diligence efforts.

• Pricing Volatility: Due to supply constraints and raw material costs, API prices can fluctuate significantly.

---

Conclusion

Procuring bulk demecarium bromide API involves navigating a highly specialized supply market dominated by select Asian and European chemical manufacturers. Ensuring quality, regulatory compliance, and supply stability requires strategic sourcing from reputable suppliers with established GMP certifications and robust quality management systems.

Pharmaceutical companies must assess supplier track records, manufacturing capabilities, and regulatory dossiers thoroughly. Emphasizing supply chain diversification and engaging with contract manufacturing organizations can mitigate risks associated with limited availability.

---

Key Takeaways

• Limited Supplier Base: Demecarium bromide API production is niche, predominantly supplied by Asian and European specialized chemical manufacturers.

• Quality & Compliance Priority: Selecting suppliers with GMP certification, robust quality controls, and regulatory documentation is critical.

• Supply Chain Resilience: Diversification across regions and engaging CMOs enhances supply stability.

• Market Outlook: Rising demand in ophthalmic therapeutics and advances in synthesis methods may influence future supply dynamics.

• Due Diligence Essential: Rigorous supplier qualification and continuous monitoring safeguard against quality, regulatory, and supply risks.

---

FAQs

1. Are there any major pharmaceutical companies manufacturing demecarium bromide API in-house?
Currently, most pharmaceutical companies outsource or procure demecarium bromide API from specialized chemical manufacturers rather than producing it in-house, due to its niche status and complex synthesis.

2. What region offers the most reliable sources for demecarium bromide API?
Asia, particularly China and India, dominates global production owing to cost-effective manufacturing capabilities and growing infrastructure for specialty APIs.

3. What regulatory considerations should be made when sourcing demecarium bromide API?
Ensure suppliers possess GMP certifications, validated manufacturing processes, comprehensive CMC documentation, and compliance with international pharmacopoeia standards to meet regulatory approval processes.

4. How can procurement risks associated with limited API suppliers be mitigated?
Develop relationships with multiple suppliers, verify regulatory and quality compliance, incorporate contractual safeguards, and consider entering long-term agreements to ensure supply continuity.

5. Are research-grade demecarium bromide suitable for pharmaceutical manufacturing?
No. Research-grade chemicals lack the necessary regulatory compliance and purity levels required for pharmaceutical use. Only APIs meeting GMP standards are suitable for medicinal products.

---

References

[1] U.S. Pharmacopeia, USP Monograph on Demecarium Bromide.
[2] European Pharmacopoeia, Monograph on Cholinesterase Inhibitors.
[3] Chemical Suppliers’ Data Sheets and CMC dossiers.
[4] Industry market analyses from Pharmaceutical Technology and CPhI Reports.